NCT02962414 2026-02-03Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentNovartisPhase 3 Active not recruiting206 enrolled
NCT05059327 2025-06-04Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSCNoema Pharma AGPhase 2 Completed61 enrolled
NCT03098589 2025-03-30Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)CelgeneCompleted1,149 enrolled
NCT04430842 2023-01-18Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072SQuadriga Biosciences, Inc.Phase 1 Completed15 enrolled
NCT02544750 2022-07-14An Open-label Extension Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)Jazz PharmaceuticalsPhase 3 Completed199 enrolled 14 charts